Bladder Cancer

Latest News

EV/pembrolizumab under review in China for advanced urothelial carcinoma
EV/pembrolizumab under review in China for advanced urothelial carcinoma

March 28th 2024

The sBLA is supported by findings from the phase 3 EV-302 trial, which showed that EV/pembrolizumab extended overall survival and progression-free survival vs platinum-based chemotherapy in patients with advanced urothelial carcinoma.

Urine-based assay demonstrates predictive efficacy in MIBC
Urine-based assay demonstrates predictive efficacy in MIBC

March 27th 2024

FDA approval sought for UGN-102 for low-grade intermediate-risk NMIBC
FDA approval sought for UGN-102 for low-grade intermediate-risk NMIBC

March 15th 2024

Liquid biopsy tests may enhance bladder cancer detection
Liquid biopsy tests may enhance bladder cancer detection

March 11th 2024

FDA approves nivolumab plus cisplatin/gemcitabine in urothelial carcinoma
FDA approves nivolumab plus cisplatin/gemcitabine in urothelial carcinoma

March 7th 2024

Video Series
Video Interviews
Podcasts
medical depiction of bladder cancer

More News

© 2024 MJH Life Sciences

All rights reserved.